1. Infection Control, Antimicrobial Consumption, and Hospital-Acquired Clostridioides difficile Infection in Acute-Care Hospitals in Catalonia
- Author
-
Montserrat Giménez, Lucía Boix-Palop, Laia Castellà, Nieves Sopena, Sergi Hernández, Juan Pablo Horcajada, Santiago Grau, Nieves Larrosa, A. Hornero, Susana Melendo, and Esther Calbo
- Subjects
Microbiology (medical) ,Consumption (economics) ,medicine.medical_specialty ,genetic structures ,Epidemiology ,medicine.drug_class ,business.industry ,Antibiotics ,Regression analysis ,Antimicrobial ,symbols.namesake ,Infectious Diseases ,Internal medicine ,Acute care ,medicine ,symbols ,Infection control ,Antimicrobial stewardship ,Poisson regression ,business - Abstract
Background: Hospital-acquired Clostridioides difficile infection (HA-CDI) is a major infection control challenge. Using whole-genome sequencing, 500 beds), 9 hospitals; group 2 (500–200 beds), 15 hospitals; and group 3 (P < .001) and a lack of association with HA-MRSA (IRR, 0.83; 95% CI, 0.46–1.48; P = .52). Conclusions: The HA-CDI incidence rate grew annually by 5% for an increase of 1 DDD in annual antibiotic consumption. No association HA-MRSA rates was detected, suggesting that antimicrobial stewardship programs are urgently needed to improve the control of HA-CDI in Catalonia, a geographical area with a low prevalence of epidemic ribotypes.Funding: NoneDisclosures: Juan Pablo Horcajada reports consulting fees from MSD, Pfizer, and Menarini and speaker honoraria from MSD, Pfizer, and Zambon.
- Published
- 2020
- Full Text
- View/download PDF